References
- Alarconsegovia D, Llorente L. Antibody penetration into living cells. 4. Different effects of anti-native DNA and anti-ribonucleoprotein IgG on the cell-cycle of activated T-gamma-cells. Clinical and Experimental Immunology 52, 365–71, 1983
- Bersan E, Volk HA, Ros C, De Risio L. Phenobarbitone-induced haematological abnormalities in idiopathic epileptic dogs: prevalence, risk factors, clinical presentation and outcome. Veterinary Record 175, 247–51, 2014 doi: 10.1136/vr.102158
- Bunch SE, Castleman WL, Hornbuckle WE, Tennant BC. Hepatic cirrhosis associated with long-term anticonvulsant drug therapy in dogs. Journal of the American Veterinary Medical Association 181, 357–62, 1982
- Dayrell-Hart B, Steinberg SA, Vanwinkle TJ, Farnbach GC. Hepatotoxicity of phenobarbital in dogs – 18 cases (1985–1989). Journal of the American Veterinary Medical Association 199, 1060–6, 1991
- Ducote JM, Coates JR, Dewey CW, Kennis RA. Suspected hypersensitivity to phenobarbital in a cat. Journal of Feline Medicine and Surgery 1, 123–6, 1999 doi: 10.1016/S1098-612X(99)90069-4
- Makino T, Kinoshita J, Arakawa S, Ito K, Ando Y, Yamoto T, Teranishi M, Sanbuissho A, Nakayama H. Comprehensive analysis of hepatic gene and protein expression profiles on phenobarbital- or clofibrate-induced hepatic hypertrophy in dogs. Journal of Toxicological Sciences 34, 647–61, 2009 doi: 10.2131/jts.34.647
- Mansur AT, Yasar SP, Goktay F. Anticonvulsant hypersensitivity syndrome: clinical and laboratory features. International Journal of Dermatology 47, 1184–9, 2008 doi: 10.1111/j.1365-4632.2008.03827.x
- March PA, Hillier A, Weisbrode SE, Mattoon JS, Johnson SE, DiBartola SP, Brofman PJ. Superficial necrolytic dermatitis in 11 dogs with a history of phenobarbital administration (1995–2002). Journal of Veterinary Internal Medicine 18, 65–74, 2004
- Menegat MB, Wouters ATB, Wouters F, Watanabe TTN, Souza SO, Driemeier D. Chronic hepatopathy in dogs due to long-term treatment with phenobarbital. Semina-Ciencias Agrarias 35, 351–6, 2014 doi: 10.5433/1679-0359.2014v35n1p351
- Mori M, Van Esbroeck M, Depoorter S, Decaluwe W, Vandecasteele SJ, Fretin D, Reynders M. Outbreak of leptospirosis during a scout camp in the Luxembourg Belgian province, Belgium, summer 2012. Epidemiology and Infection 143, 1761–6, 2015. doi: 10.1017/S0950268814002763
- Romano A, Pettinato R, Andriolo M, Viola M, Gueant-Rodriguez R-M, Valluzzi RL, Romano C, Elia M, Ventura MT, Gueant JL. Hypersensitivity to aromatic anticonvulsants: in vivo and in vitro cross-reactivity studies. Current Pharmaceutical Design 12, 3373–81, 2006 doi: 10.2174/138161206778193962
- Schlienger RG, Shear NH. Antiepileptic drug hypersensitivity syndrome. Epilepsia 39 (Suppl 7), S3–7, 1998 doi: 10.1111/j.1528-1157.1998.tb01678.x
- Schuller S, Callanan JJ, Worrall S, Francey T, Schweighauser A, Kohn B, Klopfleish R, Posthaus H, Nally JE. Immunohistochemical detection of IgM and IgG in lung tissue of dogs with leptospiral pulmonary haemorrhage syndrome (LPHS). Comparative Immunology, Microbiology and Infectious Diseases 40, 47–53, 2015 doi: 10.1016/j.cimid.2015.04.002